Evolving Resistance Patterns of Streptococcus pneumoniae: A Link with Long-Acting Macrolide Consumption?

REFERENCES

• Grüneberg RN, Felmingham D and the Alexander Project Group. Results of the Alexander Project: a continuing multicenter study of the antimicrobial susceptibility of community-acquired lower respiratory tract bacterial pathogens. Diagn Microbiol Infect Dis 1996; 25: 169–181.
   Google Scholar
• Brelmann RF, Butler JC, Tenover FC, Elliott JA, Facklam RR. Emergence of drug-resistant pneumococcal infections in the United States. JAMA 1994; 271: 1831–1835.
   PubMed Web of Science ®Google Scholar
• Schito GC, ManeIli S, Pesce A and the Alexander Project Group. Trends in the activity of macrolide and ß-lac-tam antibiotics and resistance development. J Chemother 1997; 9 (Suppl 3): 18–28.
   Google Scholar
• Bottger EC. Resistance to drugs targeting protein synthesis in mycobacteria. Trends Microbiol 1994 Oct; 2: 416–21.
   PubMedGoogle Scholar
• Baquero F. 1996 Trends in antibiotic resistance of respiratory pathogens: an analysis and commentary on a collabora-tive surveillance study. J Antimicrob Chemother 38 ( Suppl A):117-132.
   Google Scholar
• Seppälä H, Klaukka T, Vuopio-Varkila J, Muotilala A, Helenius H, Lager K, Huovinen P. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. N Engl J Med 1997; 337: 441–446.
   PubMed Web of Science ®Google Scholar
• Felmingham D, Grtineberg RN. A multicentre collaborative study of the antimicrobial susceptibility of community-acquired lower respiratory tract pathogens 1992-1993: the Alexander Project. J Antimicrob Chemother 1996; 38 ( Suppl A): 1-58.
   Google Scholar
• Geslin P, Buu-Hoi A, Fremaux A, Acar JF. Antimicrobial resistance in Streptococcus pneumoniae: an epidemiological survey in France, 1970-1990. Clin Infect Dis 1992; 15: 95–98.
   PubMed Web of Science ®Google Scholar
• Perez-Trallero E, Urbieta M, Montes M, Ayestaran I, Marimon JM. Emergence of Streptococcus pyogenes strains resistant to erythromycin in Gipuzkoa, Spain. Eur J Clin Microbiol Infect Dis 1998; 17: 25–31.
   PubMed Web of Science ®Google Scholar
• Fenoll A, Martin Bourgon C, Munoz R, Vicioso D, Casal J. Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae isolates causing systemic infections in Spain, 1979-1989. Rev Infect Dis 1991; 13 (1): 56–60.
   PubMedGoogle Scholar
• Liñares J, PaHares R, Alonso T, et al. Trends in antimicrobial resistance of clinical isolates of Streptococcus pneumoniae in Bellvitge Hospital, Barcelona, Spain (1979-1990). Clin Infect Dis 1992; 15 (1): 99–105.
   PubMed Web of Science ®Google Scholar
• Aszkenasy OM, George RC, Begg NT. Pneumococcal bacteraemia and meningitis in England and Wales 1982 to 1992. Commun Dis Rep CDR Rev 1995; 5 (4): R45–50.
   PubMedGoogle Scholar
• Spika JS, Facklam RR, Plikaytis BD, Oxtoby MJ. Antimicrobial resistance of Streptococcus pneumoniae in the United States, 1979-1987. The Pneumococcal Surveillance Working Group. J Infect Dis 1991; 163 (6): 1273–8.
   PubMed Web of Science ®Google Scholar
• Hofmann J, Cetron MS, Farley MM, et al. The prevalence of drug-resistant Streptococcus pneumoniae in Atlanta. N Engl J Med 1995; 333 (8): 481–6.
   PubMed Web of Science ®Google Scholar
• Duchin JS, Breiman RF, Diamond A, et al. High prevalence of multidrug-resistant Streptococcus pneumoniae among children in a rural Kentucky community. Pediatr Infect Dis J 1995; 14 (9): 745–50.
   PubMed Web of Science ®Google Scholar
• Butler JC, Hofmann J, Cetron MS, Elliott JA, Facklam RR, Breiman RF. The continued emergence of drug-resistant Streptococcus pneumoniae in the United States: an update from the Centers for Disease Control and Prevention's Pneumococcal Sentinel Surveillance System. J Infect Dis 1996; 174 (5): 986–93.
   PubMed Web of Science ®Google Scholar
• Moreno S, Garcia-Leoni ME, Cercenado E, et al. Infections caused by erythromycin-resistant Streptococcus pneumoniae: incidence, risk factors, and response to therapy in a prospective study. Clin Infect Dis 1995; 20 (5): 1195–200.
   PubMed Web of Science ®Google Scholar
• Martinez-Martinez L, Lopez-Hernandez I, Pascual A, Suarez Al, Perea EJ. Resistance of Streptococcus pneumoniae to penicillin, erythromycin and third-generation cephalosporins in Seville, Southern Spain. Clin Microbiol Infect 1997; 3: 382–85.
   PubMedGoogle Scholar
• Geslin P, Fremaux A, Sissia G, Spicq C, Aberrane S. Epidemiology of pneumococcal resistance to antibiotics in France. National Cooperative Survey (1984-1993). Epidemiologie de la resistance aux antibiotiques de Streptococcus pneumoniae en France. Reseau national de surveillance (1984-1993). Med Mal Infect 1994; 24: Special, 948-61.
   Google Scholar
• del Castillo F, Baquero-Artigao F, Garcia-Perea A. Influence of recent antibiotic therapy on antimicrobial resistance of Streptococcus pneumoniae in children with acute otitis media in Spain. Pediatr Infect Dis J 1998; 17 (2): 94–7.
   PubMed Web of Science ®Google Scholar
• Baquero F, Negri M. Strategies to minimize the development of antibiotic resistance. J Chemother 1997; 9 (Suppl 3): 29–37.
   PubMed Web of Science ®Google Scholar
• Drusano GL, Craig WA. Relevance of pharmacokinetics and pharmacodynamics in the selection of antibiotics for respiratory tract infections. J Chemother 1997; 9 (Suppl 3): 38–44.
   PubMed Web of Science ®Google Scholar
• Pankuch GA, Jueneman SA, Davies TA, Jacobs MR, Appelbaum PC. In vitro selection of resistance to four ß-lac-tams and azithromycin in Streptococcus pneumoniae. Antimicrob Agents Chemother 1998; 42: 2914–18.
   PubMed Web of Science ®Google Scholar